Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study.
Sikov WM, Dizon DS, Strenger R, Legare RD, Theall KP, Graves TA, Gass JS, Kennedy TA, Fenton MA. Sikov WM, et al. Among authors: dizon ds. J Clin Oncol. 2009 Oct 1;27(28):4693-700. doi: 10.1200/JCO.2008.21.4163. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720916 Clinical Trial.
Sexual ramifications of medical illness.
Perez K, Gadgil M, Dizon DS. Perez K, et al. Among authors: dizon ds. Clin Obstet Gynecol. 2009 Dec;52(4):691-701. doi: 10.1097/GRF.0b013e3181bf4b4c. Clin Obstet Gynecol. 2009. PMID: 20393421 Review.
Breast cancer: adjuvant modalities.
Sakr BJ, Dizon DS. Sakr BJ, et al. Among authors: dizon ds. Clin Obstet Gynecol. 2011 Mar;54(1):150-6. doi: 10.1097/GRF.0b013e31820838df. Clin Obstet Gynecol. 2011. PMID: 21278514
Novel antiangiogenic therapies in ovarian cancer.
Stuckey A, Dizon DS. Stuckey A, et al. Among authors: dizon ds. Womens Health (Lond). 2012 Jul;8(4):447-53. doi: 10.2217/whe.12.26. Womens Health (Lond). 2012. PMID: 22757735 Free article.
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Pinotti G, Puglisi F, Crivellari D, Ruhstaller T, Winer EP, Rabaglio-Poretti M, Maibach R, Ruepp B, Giobbie-Hurder A, Price KN, Bernhard J, Luo W, Ribi K, Viale G, Coates AS, Gelber RD, Goldhirsch A, Francis PA; TEXT and SOFT Investigators; International Breast Cancer Study Group. Pagani O, et al. N Engl J Med. 2014 Jul 10;371(2):107-18. doi: 10.1056/NEJMoa1404037. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881463 Free PMC article. Clinical Trial.
237 results